Cary Street Partners Investment Advisory’s Pfizer PFE Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176K	Sell	7,294 -497	-6%	-$13K	0.04%	401
2026 Q1	$219K	Buy	7,791 +376	+5%	+$10K	0.06%	330
2025 Q4	$185K	Sell	7,415 -983	-12%	-$24.8K	0.05%	345
2025 Q3	$214K	Buy	8,398 +3,457	+70%	+$85.3K	0.09%	250
2025 Q2	$120K	Buy	4,941 +2,182	+79%	+$50.9K	0.06%	308
2025 Q1	$69.9K	Sell	2,759 -630	-19%	-$16.5K	0.04%	338
2024 Q4	$89.9K	Sell	3,389 -132,430	-98%	-$3.59M	0.06%	267
2024 Q3	$3.93M	Sell	135,819 -4,338	-3%	-$127K	0.14%	162
2024 Q2	$3.92M	Sell	140,157 -4,745	-3%	-$131K	0.16%	152
2024 Q1	$4.02M	Sell	144,902 -10,076	-7%	-$280K	0.17%	149
2023 Q4	$4.46M	Sell	154,978 -12,054	-7%	-$364K	0.21%	133
2023 Q3	$5.54M	Buy	167,032 +22,276	+15%	+$788K	0.3%	94
2023 Q2	$5.31M	Buy	144,756 +3,026	+2%	+$118K	0.34%	77
2023 Q1	$5.78M	Buy	141,730 +467	+0.3%	+$20.2K	0.42%	65
2022 Q4	$7.24M	Sell	141,263 -4,676	-3%	-$224K	0.53%	53
2022 Q3	$6.39M	Buy	145,939 +20,184	+16%	+$981K	0.53%	54
2022 Q2	$6.59M	Buy	125,755 +103,647	+469%	+$5.28M	0.56%	53
2022 Q1	$1.15M	Buy	22,108 +6,936	+46%	+$360K	0.31%	97
2021 Q4	$896K	Buy	15,172 +1,638	+12%	+$81.2K	0.25%	103
2021 Q3	$582K	Buy	13,534 +554	+4%	+$24.5K	0.19%	122
2021 Q2	$508K	Buy	12,980 +779	+6%	+$30.3K	0.16%	131
2021 Q1	$442K	Sell	12,201 -59,649	-83%	-$2.12M	0.18%	131
2020 Q4	$2.65M	Buy	71,850 +45,398	+172%	+$1.67M	0.51%	47
2020 Q3	$921K	Buy	26,452 +15,206	+135%	+$533K	0.19%	132
2020 Q2	$348K	Buy	+11,246	New	+$382K	0.49%	61
2020 Q1	–	Sell	-8,137	Closed	-$302K	–	108
2019 Q4	$302K	Buy	+8,137	New	+$290K	0.33%	81
2018 Q4	$339K	Buy	+8,194	New	+$340K	0.33%	56

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Cary Street Partners Investment Advisory's PFE Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $13K and leaving 7,294 shares worth $176K. The position accounts for 0.04% of the portfolio, ranked #401.

Cary Street Partners Investment Advisory first reported a position in PFE in Q4 2018 and has held it in 27 quarters since. The position peaked at $7.24M in Q4 2022. 2,385 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cary Street Partners Investment Advisory held 7,294 shares of Pfizer worth $176K as of Q2 2026.
Cary Street Partners Investment Advisory sold 497 Pfizer shares in Q2 2026, an estimated $13K.
Pfizer made up 0.04% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #401 holding.
Cary Street Partners Investment Advisory first reported a position in Pfizer in Q4 2018 and has held it in 27 quarters since.
Cary Street Partners Investment Advisory's Pfizer position peaked at $7.24M in Q4 2022.
2,385 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.